Anbio Biotechnology
(NASDAQ) NNNN
Anbio Biotechnology Financials at a Glance
Market Cap
$489.39MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$14.30M
Net Income (TTM)
$7.16M
EPS (TTM)
$0.16
P/E Ratio
68.11
Dividend
$0.00
Beta (Volatility)
0.43 (Low)
Dividend
$0.00
Beta (Volatility)
0.43 (Low)
Price
$9.43
Volume
56,446
Open
$10.94
Price
$9.43
Volume
56,446
Open
$10.94
Previous Close
$9.39
Daily Range
$8.30 - $11.20
52-Week Range
$8.30 - $55.65
Estimated Earnings Date
Jul 7, 2026
Dividend
$0.00
Beta (Volatility)
0.43 (Low)
Price
$9.43
Volume
56,446
Open
$10.94
Previous Close
$9.39
Daily Range
$8.30 - $11.20
52-Week Range
$8.30 - $55.65
Estimated Earnings Date
Jul 7, 2026
NNNN News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Anbio Biotechnology
Industry
Biotechnology
Sector
Health CareEmployees
27
CEO
Michael Lau, PhD, MBA
Website
www.anbio.comHeadquarters
Frankfurt am Main, HE 60437, DE
NNNN Financials
Key Financial Metrics (TTM)
Gross Margin
86.10%
Operating Margin
65.20%
Net Income Margin
72.09%
Return on Equity
27.49%
Return on Capital
19.13%
Return on Assets
28.07%
Earnings Yield
1.47%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$489.39MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
43.89M
Volume
56.45K
Avg. Volume
35.20K
Financials (TTM)
Gross Profit
$12.28M
Operating Income
$5.94M
EBITDA
$5.15M
Operating Cash Flow
$2.25M
Capital Expenditure
-$1.36
Free Cash Flow
$2.25M
Cash & ST Invst.
$11.90M
Total Debt
$0.00
Anbio Biotechnology Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$4.74M
-25.1%
Gross Profit
$3.86M
-8.7%
Gross Margin
81.49%
N/A
Market Cap
$489.39MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$18.13M
N/A
Employees
27
N/A
Net Income
$3.04M
-21.8%
EBITDA
$2.80M
-28.0%
Quarterly Fundamentals
Total Cash
$11.90M
+15.4%
Total Debt
$0.00
N/A
Accounts Receivable
$3.66M
-20.8%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
28.07%
N/A
Return on Invested Capital
25.46%
N/A
Free Cash Flow
$0.00
+100.0%
Operating Cash Flow
$0.00
+100.0%